96
Participants
Start Date
November 14, 2019
Primary Completion Date
December 31, 2025
Study Completion Date
July 31, 2026
FF-10850 Topotecan Liposome Injection
FF-10850 to be diluted and infused over 60 minutes.
Icahn School of Medicine at Mount Sinai, New York
Ohio State University Wexner Medical Center, Columbus
University of Wisconsin Clinical Science Center, Madison
MD Anderson Cancer Center, Houston
Sarah Cannon Research Institute at HealthONE, Denver
HonorHealth, Scottsdale
Dana Farber Cancer Institute (DFCI), Boston
Lead Sponsor
Fujifilm Pharmaceuticals U.S.A., Inc.
INDUSTRY